Hold time study in Pharmaceutical industry


-Definition:
-Hold time is defined as time period for which materials (intermediates and bulk dosage form awaiting final packaging) may be held under specified conditions and will remain within the defined specifications.

-Following the objective of holding time study:
      Product remains stable before processing to the next stage
      meets the acceptance criteria for the finished product
      meets its stability specifications

-Hold-time studies establish the time limits for holding the materials at different stages of production to ensure that the quality of the product does not produce results outside the acceptance criteria during the hold time. 

-Hold times should normally be determined prior to marketing of a product.
 
-Manufacturers should gather sufficient data to demonstrate that a product for that holding time study shall be performed.

 -Written protocol of the holding time study shall be prepared before the execution of the protocol.

-Protocol shall be include following content, Purpose, scope, responsibility,  frequency for sampling, type of packing container and storage condition, test parameters, acceptance criteria.

-Microbiological analysis shall be performed if required.

-Hold times should be determined prior to marketing of a product and following any significant changes in processes, equipment, packaging materials, etc.

-Hold-time data under specified conditions should demonstrate comparable stability to the dosage form in the marketed package.

No comments:

Post a Comment